Neuronostics develop digital solutions to support healthcare professionals in the diagnosis, prognosis and management of neurological conditions.

BioEP, the primary technology, is a digital biomarker which indicates likelihood of future epileptic seizures from clinical EEG recordings. The biomarker can be used to support a diagnosis of epilepsy or differential diagnosis from first EEG, speeding up the diagnostic pathway. It also provides an objective measure of treatment response and can be used to guide therapeutic strategy.